Literature DB >> 26490846

Oral cavity squamous cell carcinoma metastatic to central compartment (level 6) lymph nodes.

Ilya Likhterov1, Meghan E Rowe1,2, Azita S Khorsandi3, Mark L Urken1,2,4.   

Abstract

Alterations to drainage pathways in the head and neck as a result of surgical manipulation are not well understood. We present two unusual cases of oral squamous cell carcinoma metastatic to the level 6 nodal compartment following extensive treatment. Both oral squamous cell carcinoma cases exhibited metastases to the central neck compartment following extensive surgery and radiation. Each patient had prior history of multifocal oral cavity disease and recurrent neck metastases requiring salvage lymphadenectomy. Surgical interventions may alter the usual lymphatic drainage patterns. In cases of extensive treatment, all levels of the neck should be monitored for lymph node recurrence. Laryngoscope, 126:1803-1805, 2016.
© 2015 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Oral cavity; central neck metastasis; lymphatic drainage; radiation therapy; reconstructive surgery

Mesh:

Year:  2015        PMID: 26490846     DOI: 10.1002/lary.25740

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

1.  Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.

Authors:  Jonathan E Leeman; Jin-Gao Li; Xin Pei; Praveen Venigalla; Zachary S Zumsteg; Evangelia Katsoulakis; Eitan Lupovitch; Sean M McBride; Chiaojung J Tsai; Jay O Boyle; Benjamin R Roman; Luc G T Morris; Lara A Dunn; Eric J Sherman; Nancy Y Lee; Nadeem Riaz
Journal:  JAMA Oncol       Date:  2017-11-01       Impact factor: 31.777

2.  Central neck lymph node metastasis in oral squamous cell carcinoma at the floor of mouth.

Authors:  Songtao Zhang; Runfang Zhang; Chao Wang; Wenbo Gong; Miaomiao Xue; Lina Liu; Yuanyuan Zhang
Journal:  BMC Cancer       Date:  2021-03-05       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.